SARS-CoV-2, strain hCoV-19/Italy/LAZ-INMI-642isl/2021, clade G, lineage B.1.617.1, VUM (former VOI Kappa) | EVAg
![Neutralizing Antibody Activity Against SARS-CoV-2 Variants in Gestational Age-Matched Mother-Infant Dyads | medRxiv Neutralizing Antibody Activity Against SARS-CoV-2 Variants in Gestational Age-Matched Mother-Infant Dyads | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/12/11/2021.12.09.21267557/F2.large.jpg)
Neutralizing Antibody Activity Against SARS-CoV-2 Variants in Gestational Age-Matched Mother-Infant Dyads | medRxiv
![CoV2K model, a comprehensive representation of SARS-CoV-2 knowledge and data interplay | Scientific Data CoV2K model, a comprehensive representation of SARS-CoV-2 knowledge and data interplay | Scientific Data](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41597-022-01348-9/MediaObjects/41597_2022_1348_Fig1_HTML.png)
CoV2K model, a comprehensive representation of SARS-CoV-2 knowledge and data interplay | Scientific Data
![Zoonotic Diseases | Free Full-Text | Tracking Co-Occurrence of N501Y, P681R, and Other Key Mutations in SARS-CoV-2 Spike for Surveillance Zoonotic Diseases | Free Full-Text | Tracking Co-Occurrence of N501Y, P681R, and Other Key Mutations in SARS-CoV-2 Spike for Surveillance](https://www.mdpi.com/zoonoticdis/zoonoticdis-02-00014/article_deploy/html/images/zoonoticdis-02-00014-g001.png)
Zoonotic Diseases | Free Full-Text | Tracking Co-Occurrence of N501Y, P681R, and Other Key Mutations in SARS-CoV-2 Spike for Surveillance
![Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants - ScienceDirect Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2001037022000344-gr5.jpg)
Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants - ScienceDirect
![Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants | Scientific Reports Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-17071-9/MediaObjects/41598_2022_17071_Fig5_HTML.png)
Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants | Scientific Reports
Antiviral activity of IgG fractions eluted from day-60 sera of high and... | Download Scientific Diagram
![Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants | Scientific Reports Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-17071-9/MediaObjects/41598_2022_17071_Fig1_HTML.png)
Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants | Scientific Reports
![Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants | Scientific Reports Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-17071-9/MediaObjects/41598_2022_17071_Fig4_HTML.png)
Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants | Scientific Reports
![Early detection and improved genomic surveillance of SARS-CoV-2 variants from deep sequencing data - ScienceDirect Early detection and improved genomic surveillance of SARS-CoV-2 variants from deep sequencing data - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589004222007581-fx1.jpg)